PFPT
MRNA icon

Pinnacle Financial Partners (Tennessee)’s Moderna MRNA Stock Holding History

Pinnacle Financial Partners (Tennessee)’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-826
Closed -$118K – 549
2022
Q2 		$118K Hold
826
– – ﹤0.01% 359
2022
Q1 		$142K Hold
826
– – ﹤0.01% 364
2021
Q4 		$210K Sell
826
-833
-50% -$244K 0.01% 376
2021
Q3 		$638K Buy
1,659
+983
+145% +$363K 0.02% 260
2021
Q2 		$159K Buy
+676
New +$121K 0.01% 360

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Pinnacle Financial Partners (Tennessee)'s MRNA Position: Q3 2022 in Review

Pinnacle Financial Partners (Tennessee) sold out of Moderna (MRNA) in Q3 2022, closing a stake of 826 shares — an estimated $118K sold.

Pinnacle Financial Partners (Tennessee) first reported a position in MRNA in Q2 2021 and held it in 5 quarters. The position peaked at $638K in Q3 2021. 916 funds tracked by Wall St. Rank hold MRNA as of Q3 2022.

  • Pinnacle Financial Partners (Tennessee) reported no remaining Moderna position as of Q3 2022 after selling out during the quarter.
  • Pinnacle Financial Partners (Tennessee) sold 826 Moderna shares in Q3 2022, an estimated $118K.
  • Pinnacle Financial Partners (Tennessee) first reported a position in Moderna in Q2 2021 and held it in 5 quarters.
  • Pinnacle Financial Partners (Tennessee)'s Moderna position peaked at $638K in Q3 2021.
  • 916 funds tracked by Wall St. Rank held Moderna as of Q3 2022.

Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q3 2022, filed 31 Oct 2022.